Skip to main content

Table 1 Description of study population

From: Community care coordination for stroke survivors: results of a complex intervention study

Characteristics Intervention group (coordinated care) Control group (usual care)
  Telephone group
n = 61
Face-to-face group
n = 30
Standardized mean difference between intervention sub-groups Total
n = 91
Total
n = 270
Standardized mean difference between intervention and control group
Sex, % (n)
 Female 42.6 (26) 56.7 (17) 0.28 47.3 47.4 (128) < 0.01
 Male 57.4 (35) 43.3 (13) 52.7 52.6 (142)
Age, mean (SD)
 All 75.4 (9.3) 75.0 (9.2) 0.04 75.3 (9.2) 75.2 (9.5) < 0.01
 Female 78.0 (9.0) 77.1 (9.0) 77.6 (8.9) 77.6 (8.8)
 Male 73.5 (9.2) 72.3 (9.0) 73.2 (9.1) 73.0 (9.5)
Dependency before strokein degree of severity, % (n)
 None 77.0 (47) 63.3 (19) 0.22 72.5 (66) 73.7 (199) 0.04
 Degree 1 13.1 (8) 23.3 (7) 16.5 (15) 16.7 (45)
 Degree 2 8.2 (5) 13.3 (4) 9.9 (9) 8.5 (23)
 Degree 3 1.6 (1) 0.0 (0) 1.1 (1) 1.1 (3)
Stroke type, % (n)
 Ischemia 82.0 (50) 83.3 (25) 0.40 82.4 (75) 81.9 (221) 0.04
Hemorrhage 8.2 (5) 13.3 (4) 9.9 (9) 9.6 (26)
 TIA 6.6 (4) 0,0 (0) 4.4 (4) 5.2 (14)
 Non-specified stroke 3.3 (2) 3.3 (1) 3.3 (3) 3.3 (9)
 Length of stay (days) in acute hospital (including direct transfers between hospitals/ wards), median (IQR) 10.0 (6.0–16.5) 20.5 (11.8–62.5) 0.63 12.0 (8.0–29.0) 13.0 (7.0–27.0) 0.20
 Length of observation in months (max. 12 months), median (IQR) 12.0 (9.7–12.0) 12.0 (12.0–12.0) 0.16 12.0 (10.2–12.0) 12.0 (12.0–12.0) 0.80
Comorbidities, % (n)
 Diabetes 29.5 (18) 40.0 (12) 0.22 33.0 (30) 33.7 (91) 0.02
 Hypertension 80.3 (49) 76.7 (23) 0.09 79.1 (72) 66.7 (180) 0.28
 Ischemic heart disease 18.0 (11) 13.3 (4) 0.13 16.5 (15) 14.1 (38) 0.07
 Renal insufficiency 19.7 (12) 16.7 (5) 0.08 18.7 (17) 13.7 (37) 0.14
 Dementia 8.2 (5) 3.3 (1) 0.21 6.6 (6) 8.9 (24) 0.09
 Atrial fibrillation 36.1 (22) 46.7 (14) 0.21 39.6 (36) 25.9 (70) 0.29
 Cardiac insufficiency 6.6 (4) 6.7 (2) 0.01 6.6 (6) 11.1 (30) 0.16
 Obesity 4.9 (3) 6.7 (2) 0.07 5.5 (5) 5.9 (16) 0.02
 Asthma/COPD 4.9 (3) 0 (0) 0.32 3.3 (3) 5.9 (16) 0.13
 Lipid metabolism disorders 44.3 (27) 40.0 (12) 0.09 42.9 (39) 21.9 (59) 0.46
 Number of comorbidities, median (IQR) 3.0 (2.0–3.0) 3.0 (2.0–3.0) 0.02 3.0 (2.0–3.0) 2.0 (1.0–3.0) 0.28
\